As the issue of drug pricing has continued to pick up steam across congressional user fee reauthorization hearings, a new series of drug pricing proposals could catch the attention of lawmakers seeking to explore options beyond the generic drugs route to lowering prices.
Writing in the New England Journal of Medicine May 25, University of Pittsburgh School of Medicine Professor Walid Gellad and...






